Metabolomic profiling of rare cell populations isolated by flow cytometry from tissues

  1. Andrew W DeVilbiss
  2. Zhiyu Zhao
  3. Misty S Martin-Sandoval
  4. Jessalyn M Ubellacker
  5. Alpaslan Tasdogan
  6. Michalis Agathocleous
  7. Thomas P Mathews  Is a corresponding author
  8. Sean J Morrison  Is a corresponding author
  1. Children’s Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, United States
  2. Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, United States
5 figures, 1 table and 1 additional file

Figures

Figure 1 with 1 supplement
Sample processing and chromatography parameters.

(A) The number of metabolites identified with high confidence spectral database matching in whole bone marrow (WBM) samples after HILIC or reverse phase chromatography (n = 3 replicates per group …

Figure 1—source data 1

All source data for Figure 1.

https://cdn.elifesciences.org/articles/61980/elife-61980-fig1-data1-v2.xlsx
Figure 1—source data 2

Supplementary table 1A-B.

Metabolites enriched or depleted in cells sorted using 1× phosphate buffered saline (PBS) sheath fluid vs 0.5× PBS sheath fluid (fold change >2 and false discovery rate [FDR] < 0.05). Supplementary table 1b. Metabolites enriched or depleted in cells sorted using 1× PBS sheath fluid vs 0.5× PBS sheath fluid (fold change = 1.5–2 and FDR < 0.05). Correlation analysis of metabolite levels from 1× PBS versus 0.5× PBS samples: Spearman r = 0.995, y = 1.3 × −2142387. These metabolites were not significantly enriched in any metabolic pathway by pathway enrichment analysis.

https://cdn.elifesciences.org/articles/61980/elife-61980-fig1-data2-v2.xlsx
Figure 1—source data 3

Supplementary table 2A-B.

Metabolites enriched or depleted in sorted vs pipetted AML cells (fold change >2 and false discovery rate [FDR] < 0.05). Correlation analysis of sorted versus pipetted AML samples: spearman r = 0.997, y = 1.1 × +214263. Metabolites that differed between sorted and pipetted AML cells were significantly enriched in ‘cysteine and methionine metabolism’. Supplementary table 2b. Metabolites enriched or depleted in sorted versus pipetted AML cells (fold change = 1.5–2 and FDR < 0.05).

https://cdn.elifesciences.org/articles/61980/elife-61980-fig1-data3-v2.xlsx
Figure 1—source data 4

Supplementary table 3A-B.

Metabolites enriched or depleted in sorted vs pipetted ALL cells (fold change >2 and false discovery rate [FDR] < 0.05). Correlation analysis: Spearman r = 0.999, y = 1.1 × –436390. The metabolites were not significantly enriched in any metabolic pathway. Supplementary table 3b. Metabolites enriched or depleted in sorted versus pipetted ALL cells (fold change = 1.5–2 and FDR < 0.05).

https://cdn.elifesciences.org/articles/61980/elife-61980-fig1-data4-v2.xlsx
Figure 1—source data 5

Supplementary table 4A-B.

Metabolites that significantly differed between AML and ALL cells in both sorted and pipetted samples, sorted samples only, or pipetted samples only. Metabolites that significantly differed between AML and ALL cells in both sorted and pipetted samples were significantly enriched in ‘glycerophospholipid metabolism’. No pathways were enriched among metabolites that differed in only sorted samples or only in pipetted samples. Supplementary table 4b. Metabolites that significantly differed between sorted AML and ALL cells or pipetted AML and ALL cells and for which fold change was between 1.5 and 2 in either the sorted or pipetted samples (FDR < 0.05).

https://cdn.elifesciences.org/articles/61980/elife-61980-fig1-data5-v2.xlsx
Figure 1—source data 6

Supplementary table 5.

Metabolites enriched or depleted at various time points after the incubation of cell suspensions on ice. The fold change cutoff is indicated in the left column. All are false discovery rate (FDR) < 0.05. Correlation analysis: 5 min versus 15 min: Spearman r = 0.998; 5 min versus 30 min: Spearman r = 0.996; 5 min versus 60 min: Spearman r = 0.992.

https://cdn.elifesciences.org/articles/61980/elife-61980-fig1-data6-v2.xlsx
Figure 1—source data 7

Supplementary table 6A-B.

Metabolites enriched or depleted in whole bone marrow (WBM) cells isolated from cells suspended in phosphate buffered saline (PBS) versus Hank's Buffered Salt Solution (HBSS) (fold change >2 and false discovery rate [FDR] > 0.05). Correlation analysis: Spearman r = 0.960, y = 0.92 × +1759331. These metabolites were not significantly enriched in any metabolic pathway. Supplementary table 6b. Metabolites enriched or depleted in WBM cells isolated from cells suspended in PBS versus HBSS (fold change = 1.5–2 and FDR < 0.05).

https://cdn.elifesciences.org/articles/61980/elife-61980-fig1-data7-v2.xlsx
Figure 1—source data 8

The raw metabolomic analyses from experiments comparing AML and ALL cells (Figure 1H–K).

These files contain the raw counts for each metabolite in each sample and the statistical comparisons between samples for each metabolite.

https://cdn.elifesciences.org/articles/61980/elife-61980-fig1-data8-v2.xlsx
Figure 1—figure supplement 1
Chromatographic performance of lipids separated by HILIC.

(A–D) Representative chromatograms for (A) phosphatidylcholine (PC [36:2]), (B) phosphatidylethanolamine (PE [38:6]), (C) lysophosphatidylcholine (Lyso-PC [18:0]), and (D) …

Figure 2 with 2 supplements
Metabolic differences between hematopoietic stem cell (HSC)/multipotent progenitors (MPPs) and whole bone marrow (WBM) cells.

(A) Metabolites significantly above background in 10,000 sorted HSC/MPPs or WBM cells (n = 3–7 replicates per treatment in each of four independent experiments; fold change >2 and false discovery …

Figure 2—source data 1

All source data for Figure 2.

https://cdn.elifesciences.org/articles/61980/elife-61980-fig2-data1-v2.xlsx
Figure 2—source data 2

Supplementary table 1.

Metabolites enriched or depleted in sorted hematopoietic stem cell (HSC)/multipotent progenitors (MPPs) as compared to whole bone marrow (WBM) cells (fold change >2 and false discovery rate [FDR] < 0.05).

https://cdn.elifesciences.org/articles/61980/elife-61980-fig2-data2-v2.xlsx
Figure 2—figure supplement 1
Metabolites that were detected as differing between hematopoietic stem cells (HSCs)/multipotent progenitors (MPPs) and whole bone marrow (WBM) cells using the Agathocleous et al.'s method (Agathocleous et al., 2017) versus the method described in this study.

Metabolites identified by Agathocleous et al. as (A) enriched or (B) depleted in HSC/MPPs as compared to WBM cells and the results obtained for the same metabolites in the current study (data are …

Figure 2—figure supplement 2
Glycerophospholipids are enriched in hematopoietic stem cell (HSC)/multipotent progenitors (MPPs) as compared to whole bone marrow (WBM) cells.

(A) Schematic of glycerophospholipid metabolism and (B) list of phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylserines (PS), Lyso-PCs, and Lyso-PEs detected in 10,000 …

Figure 3 with 1 supplement
Metabolic differences between methotrexate-treated and control hematopoietic stem cells (HSCs) or circulating melanoma cells and primary tumors.

(A–D) Bone marrow cellularity (A) and the frequencies of CD150+CD48-Lin-Sca1+c-kit+ HSCs (B), CD150-CD48-Lin-Sca1+c-kit+multipotent progenitors (MPPs) (C), and Lin-Sca1+c-kit+ cells (D) in femurs …

Figure 3—source data 1

All source data for Figure 3.

https://cdn.elifesciences.org/articles/61980/elife-61980-fig3-data1-v2.xlsx
Figure 3—source data 2

Supplementary table 1.

Metabolites that differed between circulating melanoma cells and melanoma cells from primary subcutaneous tumors in xenografted mice (fold change >2 and p<0.05).

https://cdn.elifesciences.org/articles/61980/elife-61980-fig3-data2-v2.xlsx
Figure 3—figure supplement 1
Flow cytometry gating strategies.

(A) Flow cytometry gating strategies for isolating CD150+CD48-Lin-Sca1+c-kithematopoietic stem cells (HSCs; 0.0057% of bone marrow cells), CD150-CD48-Lin-Sca1+c-kit+multipotent progenitors (MPPs; …

Metabolomic profiling of hematopoietic stem cells (HSCs) isolated by flow cytometry.

(A) Overview of the method. (B) Metabolites detected above background in 10,000 HSCs/multipotent progenitors (MPPs) in this study (green numbers, 159 metabolites total) as compared to our prior …

Author response image 1

Tables

Key resources table
Reagent type
(species) or resource
DesignationSource or referenceIdentifiersAdditional information
Chemical compound, drugPhosphate Buffered Saline TabletSigmaCat# P4417-100TAB
Chemical compound, drugMethanol, Optima grade for LC/MSFisher ScientificCat# A456-4
Chemical compound, drugAcetonitrile, Optima Grade for LCMSFisher ScientificCat# A955-4
Chemical compound, drugMeOH, Optima Grade for LCMSFisher ScientificCat# A456-4
Chemical compound, drugWater, Optima Grade for LCMSFisher ScientificCat# W6-4
Commercial assay, kitLS magnetic enrichment columnsMiltenyiCat# 130-042-401
Commercial assay, kitMidiMACS separatorMiltenyiCat# 130-042-301
OtherPlastic microfuge tube openerUSA ScientificCat# 1400–1508For minimizing metabolite contamination when opening microfuge tubes
AntibodyFITC anti-mouse B220, clone: RA3-6B2 (rat monoclonal)TonboCat# 35–0452 U500, RRID:AB_2621690Dilution: 1:400
For bone marrow HSC isolation by flow cytometry
AntibodyFITC anti-mouse Gr-1, clone: RB6-8C5 (rat monoclonal)TonboCat# 35–5931 U500, RRID:AB_2621721Dilution: 1:400
For bone marrow HSC isolation by flow cytometry
AntibodyFITC anti-mouse Terr119, clone: TER-119 (rat monoclonal)TonboCat# 35–5921 U500, RRID:AB_2621720Dilution: 1:400
For bone marrow HSC isolation by flow cytometry
AntibodyFITC anti-mouse CD2, clone: RM2-5 (rat monoclonal)TonboCat# 35–0021 T100, RRID:AB_2621657Dilution: 1:400
For bone marrow HSC isolation by flow cytometry
AntibodyFITC anti-mouse CD3, clone: 17A2 (rat monoclonal)TonboCat# 35–0032 U100, RRID:AB_2621660Dilution: 1:400
For bone marrow HSC isolation by flow cytometry
AntibodyFITC anti-mouse CD5, clone: 53–7.3 (rat monoclonal)BiolegendCat# 100606, RRID:AB_312735Dilution: 1:400
For bone marrow HSC isolation by flow cytometry
AntibodyFITC anti-mouse CD8α, clone: 53–6.7 (rat monoclonal)TonboCat# 35–0081 U500, RRID:AB_2621671Dilution 1:400
For bone marrow HSC isolation by flow cytometry
AntibodyAPC-e780 anti-mouse c-kit, clone: 2B8 (rat monoclonal)eBiosciencesCat# 47-1171-82, RRID:AB_1272177Dilution: 1:200
For bone marrow HSC isolation by flow cytometry
AntibodyPerCP-Cy5.5 anti-mouse Sca-1, clone: D7 (rat monoclonal)BioLegendCat# 108124, RRID:AB_893615Dilution 1:200
AntibodyAPC anti-mouse CD48, clone: HM48-1 (Armenian hamster monoclonal)eBiosciencesCat# 17-0481-82, RRID:AB_469408Dilution 1:200
AntibodyPE anti-mouse CD150, clone: TC15-12F12.2 (rat monoclonal)BioLegendCat# 115904, RRID:AB_313683Dilution 1:200
AntibodyAPC anti-Mouse CD45, clone: 30-F11 (rat monoclonal)TonboCat# 20–0451 U100, RRID:AB_2621573Dilution 1:100
AntibodyAPC anti-Mouse CD31 (PECAM-1), clone: 390 (rat monoclonal)BiolegendCat# 102410, RRID:AB_312905Dilution 1:100
AntibodyAPC anti-Mouse Ter119, clone: Ter119 (rat monoclonal)TonboCat# 20–5921 U100, RRID:AB_2621609Dilution 1:100
AntibodyFITC anti-Human HLA-A, B, C, clone: G46-2.6 (mouse monoclonal)BD BiosciencesCat# 555552, RRID:AB_395935Dilution 1:20
AntibodyAnti-Mouse c-Kit, conjugated to para-magnetic beads, clone: 3C11 (rat monoclonal)MiltenyiCat# 130-091-224, RRID:AB_2753213(60 µl)
60 µl beads per3 × 108 whole bone marrow cells
AntibodyAnti-Mouse CD45, conjugated to para-magnetic beads, clone: 30-F11 (rat monoclonal)MiltenyiCat# 130-052-301, RRID:AB_2877061(3 µl)
3 µl beads per1 × 106 whole bone marrow cells
Chemical compound, drugDAPISigma-AldrichCat# D8417-10mg1 µg/ml for flow cytometry
Cell lineHuman – HNT-34 AML cell lineProvided by Jian Xu’s Laboratory at Children’s Research Institute at UT Southwestern Medical Center. Original source: DSMZACC 600, RRID: CVCL_2071
Cell lineHuman DND-41 cell lineProvided by Jian Xu’s Laboratory at Children’s Research Institute at UT Southwestern Medical Center.
Original source: Hui Feng, M.D./Ph.D.; Boston University
RRID: CVCL_2022
Cell lineHuman melanoma xenograft M405Sci Trans Med 4:159ra
PMCID:PMC4501487
M405
Strain, strain backgroundNOD.CB17-Prkdcscid Il2rgtm1Wjl/Szj (NSG) miceJackson laboratories005557, RRID:IMSR_JAX:005557
Strain, strain backgroundC57BL/Ka Thy1.1 miceDerived from Henry Kaplan’s laboratory at Stanford UniversityN/A
OtherZIC-pHILIC column (2.1 × 150, 5 μm)Millipore SigmaCat# 1504600001
Software, algorithmOmics Data Analyzer (ODA)This manuscripthttps://git.biohpc.swmed.edu/CRI/ODASee Materials and methods, section ‘Statistical analysis of metabolomics data’
Software, algorithmGraphpad Prism V8.3GraphpadRRID:SCR_002798
Software, algorithmFlowJo V10.7.1BD BiosciencesRRID:SCR_008520
Software, algorithmFreestyle V1.5Thermo ScientificN/A
Software, algorithmTrace Finder V4.0Thermo ScientificN/A
Software, algorithmCompound Discoverer V3.1Thermo ScientificN/A
Chemical compound, drugFormic Acid OptimaFisherCat# A11750
Chemical compound, drugAmmonium acetate, OptimaFisherCat# A11450
Chemical compound, drugAmmonium hydroxide, OptimaFisher scientificCat# A470-250
Chemical compound, drugMethotrexateSelleck ChemCat# S1210
Chemical compound, drugSplashMixAvantiCat# 330707

Additional files

Download links